Health Care & Life Sciences » Healthcare Provision | U.S. Neurosurgical Holdings Inc.

U.S. Neurosurgical Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
2,607.00
2,971.00
3,212.00
3,414.00
3,424
Cost of Goods Sold (COGS) incl. D&A
-
692.00
1,195.00
1,290.00
1,467.00
1,341
Gross Income
-
1,915.00
1,776.00
1,922.00
1,947.00
2,083
SG&A Expense
994.00
1,179.00
1,232.00
1,308.00
1,259.00
1,289
EBIT
994.00
736.00
544.00
-
688.00
794
Unusual Expense
-
-
-
218.00
-
-
Non Operating Income/Expense
-
237.00
-
-
-
663
Interest Expense
15.00
184.00
181.00
161.00
153.00
113
Pretax Income
1,029.00
803.00
648.00
878.00
441.00
613
Income Tax
362.00
242.00
252.00
342.00
97.00
192
Consolidated Net Income
667.00
561.00
396.00
536.00
538.00
421
Net Income
667.00
561.00
396.00
536.00
538.00
421
Net Income After Extraordinaries
667.00
561.00
396.00
536.00
538.00
421
Net Income Available to Common
667.00
561.00
396.00
536.00
538.00
421
EPS (Basic)
0.09
0.07
0.05
0.07
0.07
0.05
Basic Shares Outstanding
7,797.20
7,797.20
7,797.20
7,794.70
7,792.20
7,792.20
EPS (Diluted)
0.09
0.07
0.05
0.07
0.07
0.05
Diluted Shares Outstanding
7,797.20
7,797.20
7,797.20
7,794.70
7,792.20
7,792.20
EBITDA
994.00
1,408.00
1,514.00
1,645.00
1,849.00
1,797
Non-Operating Interest Income
11.00
-
-
5.00
7.00
112
Equity in Affiliates (Pretax)
31.00
14.00
285.00
638.00
101.00
743

About U.S. Neurosurgical Holdings

View Profile
Address
2400 Research Boulevard
Rockville Maryland 20850
United States
Employees -
Website http://www.usneuro.com
Updated 07/08/2019
U. S. Neurosurgical Holdings, Inc. engages in the acquisition and operation of technologies in medical treatment and diagnosis.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.